Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio of Shenyang in-licensed China...
3SBio, a Shenyang biopharma, will...
3SBio of Shenyang invested $15 million...
3SBio of Shenyang will pay $50 million...
Verseau Therapeutics, a Boston-area macrophage cancer...
Company Offers EPO Clone To Chinese Market. More details...
3SBio will seek to raise up to $712...
China's 3SBio acquired ex-China rights...
3SBio, a China biopharma based in...
Shenyang's 3SBio expanded its biosimilar...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
